Could Biostage Incorporated (NASDAQ:BSTG) See a Reversal After More Sellers Came In?

September 17, 2017 - By Darrin Black

 Could Biostage Incorporated (NASDAQ:BSTG) See a Reversal After More Sellers Came In?

The stock of Biostage Incorporated (NASDAQ:BSTG) registered an increase of 10.26% in short interest. BSTG’s total short interest was 4.04M shares in September as published by FINRA. Its up 10.26% from 3.66 million shares, reported previously. With 1.89 million shares average volume, it will take short sellers 2 days to cover their BSTG’s short positions. The short interest to Biostage Incorporated’s float is 11.83%.

The stock increased 3.92% or $0.012 on September 15, reaching $0.329. About 1.33 million shares traded. Biostage Inc (NASDAQ:BSTG) has declined 78.72% since September 17, 2016 and is downtrending. It has underperformed by 95.42% the S&P500.

Biostage, Inc., formerly Harvard Apparatus Regenerative Technology, Inc., is a biotechnology company. The company has market cap of $12.81 million. The Firm is engaged in developing bioengineered organ implants based on its Cellframe technology. It currently has negative earnings. The Company’s Cellframe technology consists of a biocompatible scaffold that is seeded with the recipient’s own cells.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: